| References |
| 1. |
Alabaster, V. A.
Inactivation of endogenous amines in the lungs. In:
Lung Biology in Health and Disease. Metabolic Functions of the Lung,
edited by Y. S. Bakhle and
J. R. Vane.
New York:
Dekker,
1977,
vol. 4,
chapt. 1,
p. 3–31.
|
| 2. |
Alabaster, V. A., and
Y. S. Bakhle.
Removal of 5‐hydroxy‐tryptamine in the pulmonary circulation of rat isolated lungs.
Br. J. Pharmacol.
40:
468–482,
1970.
|
| 3. |
Alabaster, V. A., and
Y. S. Bakhle.
The removal of nor‐adrenaline in the pulmonary circulation of rat isolated lungs.
Br. J. Pharmacol.
47:
325–331,
1973.
|
| 4. |
Al‐Ubaidi, F., and
Y. S. Bakhle.
Metabolism of vasoactive hormones in human isolated lung.
Clin. Sci.
58:
45–51,
1980.
|
| 5. |
Anderson, M. W.,
T. C. Orton,
R. D. Pickett, and
T. E. Eling.
Accumulation of amines in the isolated perfused rabbit lung.
J. Pharmacol. Exp. Ther.
189:
456–466,
1974.
|
| 6. |
Axelrod, J., and
J. K. Inscoe.
The uptake and binding of circulating serotonin and the effect of drugs.
J. Pharmacol. Exp. Ther.
141:
161–165,
1963.
|
| 7. |
Bakhle, Y. S., and
R. R. Ben‐Harari.
Effects of oestrous cycle and exogenous ovarian steroids on 5‐hydroxytryptamine metabolism in rat lung.
J. Physiol. London
291:
11–18,
1979.
|
| 8. |
Bakhle, Y. S., and
R. R. Ben‐Harari.
Effects of the oestrous cycle and exogenous ovarian steroids on metabolism of ã‐phenylethylamine in rat lung.
Br. J. Pharmacol.
67:
109–114,
1979.
|
| 9. |
Bakhle, Y. S., and
A. J. Block.
Effects of halothane on pulmonary inactivation of noradrenaline and prostaglandin E2 in anaesthetized dogs.
Clin. Sci. Mol. Med.
50:
87–90,
1976.
|
| 10. |
Bakhle, Y. S.,
J. Hartiala,
H. Toivonen, and
P. Uotila.
Effects of cigarette smoke on the metabolism of vasoactive hormones in rat isolated lungs.
Br. J. Pharmacol.
65:
495–499,
1979.
|
| 11. |
Bakhle, Y. S., and
J. R. Vane.
Pharmacokinetic function of the pulmonary circulation.
Physiol. Rev.
54:
1007–1045,
1974.
|
| 12. |
Bakhle, Y. S., and
M. B. H. Youdim.
The metabolism of 5‐hydroxytryptamine and ã‐phenylethylamine in perfused rat lung and in vitro.
Br. J. Pharmacol.
65:
147–154,
1979.
|
| 13. |
Ben‐Harari, R. R., and
Y. S. Bakhle.
Uptake of ã‐phenylethylamine in rat isolated lung.
Biochem. Pharmacol.
29:
489–494,
1980.
|
| 14. |
Bennett, A.
The metabolism of histamine by guinea‐pig and rat lung in vitro.
Br. J. Pharmacol.
24:
147–155,
1965.
|
| 15. |
Block, E. R.
Recovery from hyperoxic depression of pulmonary 5‐hydroxytryptamine clearance: effect of inspired O2 tension.
Lung
155:
131–140,
1978.
|
| 16. |
Block, E. R., and
J. K. Cannon.
Effect of oxygen exposure on lung clearance of amines.
Lung
155:
287–295,
1978.
|
| 17. |
Block, E. R., and
A. B. Fisher.
Depression of serotonin clearance by rat lungs during oxygen exposure.
J. Appl. Physiol: Respirat. Environ. Exercise Physiol.
42:
33–38,
1977.
|
| 18. |
Block, E. R., and
A. B. Fisher.
Effect of hyperbaric oxygen exposure on pulmonary clearance of 5‐hydroxytryptamine.
J. Appl. Physiol.: Respirat. Environ. Exercise Physiol.
43:
254–257,
1977.
|
| 19. |
Block, E. R., and
A. B. Fisher.
Prevention of hyperoxic‐induced depression of pulmonary serotonin clearance by pretreatment with superoxide dismutase.
Am. Rev. Respir. Dis.
116:
441–447,
1977.
|
| 20. |
Block, E. R., and
F. J. Schoen.
Effect of alpha naphthylthiourea on uptake of 5‐hydroxytryptamine from the pulmonary circulation.
Am. Rev. Respir. Dis.
123:
69–73,
1981.
|
| 21. |
Boileau, J. C.,
L. Campeau, and
P. Biron.
Pulmonary fate of histamine, isoproterenol, physalaemin, and substance P.
Can. J. Physiol. Pharmacol.
48:
681–684,
1970.
|
| 22. |
Boileau, J. C.,
L. Campeau, and
P. Biron.
Comparative pulmonary fate of intravenous epinephrine.
Rev. Can. Biol.
30:
281–286,
1971.
|
| 23. |
Boileau, J. C.,
C. Crexells, and
P. Biron.
Free pulmonary passage of dopamine.
Rev. Can. Biol.
31:
69–72,
1972.
|
| 24. |
Briant, R. H.,
E. W. Blackwell,
F. M. Williams,
D. S. Da Vies, and
C. T. Dollery.
The metabolism of sympathomimetic bronchodilator drugs by the isolated perfused dog lung.
Xenobiotica
3:
787–799,
1973.
|
| 25. |
Catravas, J. D., and
C. N. Gillis.
Pulmonary clearance of [14C]5‐hydroxytryptamine and [3H]norepinephrine in vivo: effects of pretreatment with imipramine or cocaine.
J. Pharmacol. Exp. Ther.
213:
120–127,
1980.
|
| 26. |
Coquil, J. F.,
C. Goridis,
G. Mack, and
N. H. Neff.
Monoamine oxidase in rat arteries: evidence for different forms and selective localization.
Br. J. Pharmacol.
48:
590–599,
1973.
|
| 27. |
Crawford, N.
The lungs and serotonin metabolism: a study of the pulmonary arterio‐venous levels of plasma free and platelet‐bound serotonin in man.
Clin. Chim. Acta
12:
264–273,
1965.
|
| 28. |
Cronau, L. H.,
M. D. Kerstein,
S. Mandel, and
C. N. Gillis.
5‐Hydroxytryptamine extraction by the lung.
Surg. Gynecol. Obstet.
143:
51–55,
1976.
|
| 29. |
Cross, S. A. M.,
V. A. Alabaster,
Y. S. Bakhle, and
J. R. Vane.
Sites of uptake of 3H‐5‐hydroxytryptamine in rat isolated lung.
Histochemistry
39:
83–91,
1974.
|
| 30. |
Davila, D., and
T. Davila.
Uptake and release of 3H‐metaraminol by rat lung. Basic aspects, ionic and energy requirements.
Arch. Int. Pharmacodyn. Ther.
214:
53–61,
1975.
|
| 31. |
Davila, T., and
D. Davila.
Uptake and release of 3H‐metar‐aminol by rat lung. The influence of various drugs.
Arch. Int. Pharmacodyn. Ther.
215:
336–344,
1975.
|
| 32. |
Davis, R. B., and
Y. Wang.
Rapid pulmonary removal of 5‐hydroxytryptamine in the intact dog.
Proc. Soc. Exp. Biol. Med.
118:
797–800,
1965.
|
| 33. |
Dollery, C. T., and
A. F. Junod.
Concentration of (+/‐)‐propranolol in isolated perfused lungs of rat.
Br. J. Pharmacol.
57:
67–71,
1976.
|
| 34. |
Eichholtz, F., and
E. B. Verney.
On some conditions affecting the perfusion of isolated mammalian organs.
J. Physiol. London
59:
340–344,
1924‐1925.
|
| 35. |
Eiseman, B.,
L. Bryant, and
T. Waltuch.
Metabolism of vasomotor agents by the isolated perfused lung.
J. Thorac. Cardiovasc. Surg.
48:
798–806,
1964.
|
| 36. |
Eling, T. E.,
R. D. Pickett,
T. C. Orton, and
M. W. Anderson.
A study of the dynamics of imipramine accumulation in the isolated perfused rabbit lung.
Drug Metab. Dispos.
3:
389–399,
1975.
|
| 37. |
Ferreira, S. H.,
K. K. Ng, and
J. R. Vane.
The continuous bioassay of the release and disappearance of histamine in the circulation.
Br. J. Pharmacol.
49:
543–553,
1973.
|
| 38. |
Fisher, A. B., and
G. G. Pietra.
Comparison of serotonin uptake from the alveolar and capillary spaces of isolated rat lung.
Am. Rev. Respir. Dis.
123:
74–78,
1981.
|
| 39. |
Fisher, A. B.,
H. Steinberg, and
C. Dodia.
Reversal of 2‐deoxyglucose inhibition of serotonin uptake in isolated guinea pig lung.
J. Appl. Physiol: Respirat. Environ. Exercise Physiol.
46:
447–450,
1979.
|
| 40. |
Fishman, A. P., and
G. G. Pietra.
Handling of bioactive materials by the lung. Pt. 1.
N. Engl. J. Med.
291:
884–890,
1974.
|
| 41. |
Fishman, A. P., and
G. G. Pietra.
Handling of bioactive materials by the lung. Pt. 2.
N. Engl. J. Med.
291:
953–959,
1974.
|
| 42. |
Fowler, C. J.,
B. A. Callingham,
T. J. Mantle, and
K. F. Tipton.
Monoamine oxidase A and B: a useful concept?
Biochem. Pharmacol.
27:
97–101,
1978.
|
| 43. |
Gaddum, J. H.,
C. O. Hebb,
A. Silver, and
A. A. B. Swan.
5‐Hydroxytryptamine. Pharmacological action and destruction in perfused lungs.
Q. J. Exp. Physiol.
38:
255–262,
1953.
|
| 44. |
Gallagher, B.,
D. Christman,
J. Fowler,
R. McGregor,
A. P. Wolf,
P. Som,
A. N. Ansari, and
H. Atkins.
Radioisotope scintigraphy for the study of dynamics of amine regulation by the human lung.
Chest
71,
Suppl.:
282–284,
1977.
|
| 45. |
Geddes, D. M.,
K. Nesbitt,
T. Traill, and
J. P. Blackburn.
First pass uptake of 14C‐propranolol by the lung.
Thorax
34:
810–813,
1979.
|
| 46. |
Gewitz, M. H., and
C. N. Gillis.
Uptake and metabolism of biogenic amines in the developing rabbit lung.
J. Appl. Physiol.: Respirat. Environ. Exercise Physiol.
50:
118–122,
1981.
|
| 47. |
Gillis, C. N.
Metabolism of vasoactive hormones by lung.
Anesthesiology
39:
626–632,
1973.
|
| 48. |
Gillis, C. N.,
L. H. Cronau,
N. M. Greene, and
G. L. Hammond.
Removal of 5‐hydroxytryptamine and norepinephrine from the pulmonary vascular space of man: influence of cardiopulmonary bypass and pulmonary arterial pressure on these processes.
Surgery
76:
608–616,
1974.
|
| 49. |
Gillis, C. N.,
L. H. Cronau,
S. Mandel, and
G. L. Hammond.
Indicator dilution measurement of 5‐hydroxytryptamine clearance by human lung.
J. Appl. Physiol.: Respirat. Environ. Exercise Physiol.
46:
1178–1183,
1979.
|
| 50. |
Gillis, C. N., and
N. M. Greene.
Possible clinical implications of metabolism of bloodborne substrates by the human lung. In:
Lung Biology in Health and Disease. Metabolic Functions of the Lung,
edited by Y. S. Bakhle and
J. R. Vane.
New York:
Dekker,
1977,
vol. 4,
chapt. 6,
p. 173–193.
|
| 51. |
Gillis, C. N.,
N. M. Greene,
L. H. Cronau, and
G. L. Hammond.
Pulmonary extraction of 5‐hydroxytryptamine and norepinephrine before and after cardiopulmonary bypass in man.
Circ. Res.
30:
666–674,
1972.
|
| 52. |
Gillis, C. N.,
R. J. Huxtable, and
R. A. Roth.
Effects of monocrotaline pretreatment of rats on removal of 5‐hydroxytryptamine and noradrenaline by perfused lung.
Br. J. Pharmacol.
63:
435–443,
1978.
|
| 53. |
Gillis, C. N., and
Y. Iwasawa.
Technique for measurement of norepinephrine and 5‐hydroxytryptamine uptake by rabbit lung.
J. Appl. Physiol.
33:
404–408,
1972.
|
| 54. |
Gillis, C. N., and
J. A. Roth.
Pulmonary disposition of circulating vasoactive hormones.
Biochem. Pharmacol.
25:
2547–2553,
1976.
|
| 55. |
Gillis, C. N., and
J. A. Roth.
The fate of biogenic monoamines in perfused rabbit lung.
Br. J. Pharmacol.
59:
585–590,
1977.
|
| 56. |
Ginn, R., and
J. R. Vane.
Disappearance of catecholamines from the circulation.
Nature London
219:
740–742,
1968.
|
| 57. |
Gruby, L. A.,
C. Rowlands,
B. Q. Varley, and
J. H. Wyllie.
The fate of 5‐hydroxytryptamine in the lungs.
Br. J. Surg.
58:
525–532,
1971.
|
| 58. |
Heinemann, H. O., and
A. P. Fishman.
Nonrespiratory functions of mammalian lung.
Physiol. Rev.
49:
1–47,
1969.
|
| 59. |
Hughes, J.,
C. N. Gillis, and
F. E. Bloom.
The uptake and disposition of dl‐norepinephrine in perfused rat lung.
J. Pharmacol. Exp. Ther.
169:
237–248,
1969.
|
| 60. |
Huxtable, R.,
D. Ciaramitaro, and
D. Eisenstein.
The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium.
Mol. Pharmacol.
14:
1189–1203,
1978.
|
| 61. |
Iversen, L. L.
Uptake mechanisms for neurotransmitter amines.
Biochem. Pharmacol.
23:
1927–1935,
1974.
|
| 62. |
Iwasawa, Y., and
C. N. Gillis.
Effect of steroid and other hormones on lung removal of noradrenaline.
Eur. J. Pharmacol.
22:
367–370,
1973.
|
| 63. |
Iwasawa, Y., and
C. N. Gillis.
Pharmacological analysis of norepinephrine and 5‐hydroxytryptamine removal from the pulmonary circulation: differentiation of uptake sites for each amine.
J. Pharmacol. Exp. Ther.
188:
386–393,
1974.
|
| 64. |
Iwasawa, Y.,
C. N. Gillis, and
G. Aghajanian.
Hypothermic inhibition of 5‐hydroxytryptamine and norepinephrine uptake by lung: cellular location of amines after uptake.
J. Pharmacol. Exp. Ther.
186:
498–507,
1973.
|
| 65. |
Junod, A. F.
Accumulation of 14C‐imipramine in isolated perfused rat lungs.
J. Pharmacol. Exp. Ther.
183:
182–187,
1972.
|
| 66. |
Junod, A. F.
Uptake, metabolism and efflux of 14C‐5‐hydroxytryptamine in isolated, perfused rat lungs.
J. Pharmacol. Exp. Ther.
183:
341–355,
1972.
|
| 67. |
Junod, A. F.
Mechanism of uptake of biogenic amines in the pulmonary circulation. In:
Lung Metabolism,
edited by A. F. Junod and
R. de Haller.
London:
Academic,
1975,
p. 387–398.
|
| 68. |
Junod, A. F.
Metabolism, production, and release of hormones and mediators in the lung.
Am. Rev. Respir. Dis.
112:
93–108,
1975.
|
| 69. |
Junod, A. F.
Uptake, release and metabolism of drugs in the lungs. In:
International Encyclopedia of Pharmacology and Therapeutics. Respiratory Pharmacology,
edited by J. G. Widdicombe.
Oxford, UK:
Pergamon,
1981,
p. 733–745.
|
| 70. |
Junod, A. F., and
C. Ody.
Amine uptake and metabolism by endothelium of pig pulmonary artery and aorta.
Am. J. Physiol.
232
(Cell Physiol.1):
C88–C94,
1977.
|
| 71. |
Krell, R. D.,
J. McCoy, and
P. Christian.
Accumulation and metabolism of [14C] histamine by rat lung in vivo.
Biochem. Pharmacol.
27:
820–821,
1978.
|
| 72. |
Larmi, T. K. I., and
E. Heikkinen.
Pulmonary degradation and cardiovascular effects of intracavally infused 5‐hydroxytryptamine in man.
Scand. J. Thorac. Cardiovasc. Surg.
1:
123–126,
1967.
|
| 73. |
Lilja, B., and
S. E. Lindell.
Metabolism of [14C]histamine in heart‐lung‐liver preparations of cats.
Br. J. Pharmacol.
16:
203–208,
1961.
|
| 74. |
McEwen, C. M., Jr.,
K. T. Cullen, and
A. J. Sober.
Rabbit serum monoamine oxidase. Purification and characterization.
J. Biol. Chem.
241:
4544–4556,
1966.
|
| 75. |
Minchin, R. F.,
B. W. Madsen, and
K. F. Ilett.
Effect of desmethylimipramine on the kinetics of chlorphentermine accumulation in isolated perfused rat lung.
J. Pharmacol. Exp. Ther.
211:
514–518,
1979.
|
| 76. |
Naito, H., and
C. N. Gillis.
Effects of halothane and nitrous oxide on removal of norepinephrine from the pulmonary circulation.
Anesthesiology
39:
575–580,
1973.
|
| 77. |
Nicholas, T. E.,
J. M. Strum,
L. S. Angelo, and
A. F. Junod.
Site and mechanism of uptake of 3H‐l‐norepinephrine by isolated perfused rat lungs.
Circ. Res.
35:
670–680,
1974.
|
| 78. |
Orton, T. C.,
M. W. Anderson,
R. D. Pickett,
T. E. Eling, and
J. R. Fouts.
Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs.
J. Pharmacol. Exp. Ther.
186:
482–497,
1973.
|
| 79. |
Pearson, J. D.,
H. J. Olverman, and
J. L. Gordon.
Transport of 5‐hydroxytryptamine by endothelial cells.
Biochem. Soc. Trans.
5:
1181–1183,
1977.
|
| 80. |
Philpot, R. M.,
M. W. Anderson, and
T. E. Eling.
Uptake, accumulation and metabolism of chemicals by the lung. In:
Lung Biology in Health and Disease. Metabolic Functions of the Lung,
edited by Y. S. Bakhle and
J. R. Vane.
New York:
Dekker,
1977,
vol. 4,
chapt. 5,
p. 123–171.
|
| 81. |
Pickett, R. D.,
M. W. Anderson,
T. C. Orton, and
T. E. Eling.
The pharmacodynamics of 5‐hydroxytryptamine uptake and metabolism by the isolated perfused rabbit lung.
J. Pharmacol. Exp. Ther.
194:
545–553,
1975.
|
| 82. |
Rickaby, D. A.,
C. A. Dawson, and
M. B. Maron.
Pulmonary inactivation of serotonin and site of serotonin pulmonary vasoconstriction.
J. Appl. Physiol: Respirat. Environ. Exercise Physiol.
48:
606–612,
1980.
|
| 83. |
Rosenbloom, P. M., and
A. D. Bass.
A lung perfusion preparation for the study of drug metabolism.
J. Appl. Physiol.
29:
138–144,
1970.
|
| 84. |
Roth, J. A., and
C. N. Gillis.
Deamination of ã‐phenylethylamine by monoamine oxidase‐inhibition by imipramine.
Biochem. Pharmacol.
23:
2537–2545,
1974.
|
| 85. |
Roth, J. A., and
C. N. Gillis.
Multiple forms of amine oxidase in perfused rabbit lung.
J. Pharmacol. Exp. Ther.
194:
537–544,
1975.
|
| 86. |
Roth, R. A., and
C. N. Gillis.
Effect of ventilation and pH on removal of mescaline and biogenic amines by rabbit lung.
J. Appl. Physiol.: Respirat. Environ. Exercise Physiol.
44:
553–558,
1978.
|
| 87. |
Roth, R. A., Jr.,
J. A. Roth, and
C. N. Gillis.
Disposition of 14C‐mescaline by rabbit lung.
J. Pharmacol. Exp. Ther.
200:
394–401,
1977.
|
| 88. |
Roth, R. A., and
K. B. Wallace.
Disposition of biogenic amines and angiotensin I by lungs of spontaneously hypertensive rats.
Am. J. Physiol.
239
(Heart Circ. Physiol. 8):
H736–H741,
1980.
|
| 89. |
Roth, R. A.,
K. B. Wallace,
R. H. Alper, and
M. D. Bailie.
Effect of paraquat treatment of rats on disposition of 5‐hydroxytryptamine and angiotensin I by perfused lung.
Biochem. Pharmacol.
28:
2349–2355,
1979.
|
| 90. |
Sabelli, H. C.,
R. L. Borison,
B. I. Diamond,
H. S. Havdala, and
N. Narasimhachari.
Phenylethylamine and brain function.
Biochem. Pharmacol.
27:
1729–1730,
1978.
|
| 91. |
Said, S. I.
The lung as a metabolic organ.
N. Engl. J. Med.
279:
1330–1334,
1969.
|
| 92. |
Said, S. I.
The lung in relation to vasoactive hormones.
Federation Proc.
32:
1972–1975,
1973.
|
| 93. |
Shepro, D.,
J. C. Batbouta,
L. S. Robblee,
M. P. Carson, and
F. A. Belamarich.
Serotonin transport by cultured bovine aortic endothelium.
Circ. Res.
36:
799–805,
1975.
|
| 94. |
Small, R.,
E. Macarak, and
A. B. Fisher.
Production of 5‐hydroxyindoleacetic acid from serotonin by cultured endothelial cells.
J. Cell. Physiol.
90:
225–232,
1976.
|
| 95. |
Sneddon, J. M.
Sodium‐dependent accumulation of 5‐hydroxytryptamine by rat blood platelets.
Br. J. Pharmacol.
37:
680–688,
1969.
|
| 96. |
Sole, M. J.,
M. Drobac,
L. Schwartz,
M. N. Hussain, and
E. F. Vaughan‐Neil.
The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension.
Circulation
60:
160–163,
1979.
|
| 97. |
Steinberg, H.,
D. J. P. Bassett, and
A. B. Fisher.
Depression of pulmonary 5‐hydroxytryptamine uptake by metabolic inhibitors.
Am. J. Physiol.
228:
1298–1303,
1975.
|
| 98. |
Steinberg, H., and
D. K. Das.
Competition between platelets and lung for 5‐hydroxytryptamine uptake.
Exp. Lung Res.
1:
121–130,
1980.
|
| 99. |
Strum, J. M., and
A. F. Junod.
Radioautographic demonstration of 5‐hydroxytryptamine‐3H uptake by pulmonary endothelial cells.
J. Cell Biol.
54:
456–467,
1972.
|
| 100. |
Thomas, D. P., and
J. R. Vane.
5‐Hydroxytryptamine in the circulation of the dog.
Nature London
216:
335–338,
1967.
|
| 101. |
Tissari, A. H., and
D. F. Bogdanski.
Biogenic amine transport. IV. Comparison of effects of ouabain and K+ deficiency on the transport of 5‐hydroxytryptamine and norepinephrine by synaptosomes.
Pharmacology
5:
225–234,
1977.
|
| 102. |
Vane, J. R.
The release and fate of vaso‐active hormones in the circulation.
Br. J. Pharmacol.
35:
209–242,
1969.
|
| 103. |
Whitby, L. G.,
J. Axelrod, and
H. Weil‐Malherbe.
The fate of H3‐norepinephrine in animals.
J. Pharmacol. Exp. Ther.
132:
193–201,
1961.
|
| 104. |
White, M. K.,
H. B. Hechtman, and
D. Shepro.
Canine lung uptake of plasma and platelet serotonin.
Microvasc. Res.
9:
230–241,
1975.
|
| 105. |
Wilson, A. G. E.,
F. C. P. Law,
T. E. Eling, and
M. W. Anderson.
Uptake, metabolism and efflux of methadone in “single pass” isolated perfused rabbit lungs.
J. Pharmacol. Exp. Ther.
199:
360–367,
1976.
|
| 106. |
Yang, H.‐Y. T., and
N. H. Neff.
The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
J. Pharmacol. Exp. Ther.
189:
733–740,
1974.
|
| 107. |
Youdim, M. B. H.,
Y. S. Bakhle, and
R. R. Ben‐Harari.
Inactivation of monoamines by the lung. In:
Metabolic Functions of the Lung.
Amsterdam:
Excerpta Med.,
1980,
p. 105–128.
(Ciba Found. Symp. 78.)
|
